NUI Galway initiates Phase I trial of daratumumab in Irish patients with multiple myeloma

The National University of Ireland (NUI) Galway has initiated the Phase I clinical trial of daratumumab combination therapy in Irish patients for the treatment of multiple myeloma.
Source: Drug Development Technology - Category: Pharmaceuticals Source Type: news